Serveur d'exploration sur la maladie de Parkinson - Exploration (Accueil)

Index « Auteurs » - entrée « Andrew Lees (neurologue) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Andrew Krahn < Andrew Lees (neurologue) < Andrew M. Gordon  Facettes :

List of bibliographic references indexed by Andrew Lees (neurologue)

Number of relevant bibliographic references: 62.
[20-40] [0 - 20][0 - 50][40-60]
Ident.Authors (with country if any)Title
000B72 (2009) Donald Grosset [Royaume-Uni] ; Angelo Antonini [Italie] ; Margherita Canesi [Italie] ; Gianni Pezzoli [Italie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Karen Shaw [Royaume-Uni] ; Esther Cubo [Espagne] ; Pablo Martinez-Martin [Espagne] ; Olivier Rascol [France] ; Laurence Negre-Pages [France] ; Ana Senard [France] ; Johannes Schwarz [Allemagne] ; Karl Strecker [Allemagne] ; Heinz Reichmann [Allemagne] ; Alexander Storch [Allemagne] ; Matthias Löhle [Allemagne] ; Fabrizio Stocchi [Italie] ; Katherine Grosset [Royaume-Uni]Adherence to antiparkinson medication in a multicenter European study
000B75 (2009) Laura Silveira-Moriyama [Royaume-Uni] ; Dharshana Sirisena [Sri Lanka] ; Pasan Gamage [Sri Lanka] ; Ranjanie Gamage [Sri Lanka] ; Rohan De Silva [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Adapting the Sniffin' Sticks to diagnose Parkinson's disease in Sri Lanka
000C28 (2008) D R Williams [Royaume-Uni] ; J D Warren [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Using the presence of visual hallucinations to differentiate Parkinson’s disease from atypical parkinsonism
000C39 (2008) Laura Silveira-Moriyama [Royaume-Uni] ; Margarete De Jesus Carvalho [Brésil] ; Regina Katzenschlager [Autriche] ; Aviva Petrie [Royaume-Uni] ; Ronald Ranvaud [Brésil] ; Egberto Reis Barbosa [Brésil] ; Andrew Lees (neurologue) [Royaume-Uni]The use of smell identification tests in the diagnosis of Parkinson's disease in Brazil
000C51 (2008) Andrew Lees (neurologue) [Royaume-Uni] ; Marianna Selikhova [Royaume-Uni] ; Luiz Augusto Andrade [Brésil] ; Charles Duyckaerts [France]The black stuff and Konstantin Nikolaevich Tretiakoff
000D28 (2008) Sean S. O'Sullivan [Royaume-Uni] ; David R. Williams [Royaume-Uni, Australie] ; David A. Gallagher [Royaume-Uni] ; Luke A. Massey [Royaume-Uni] ; Laura Silveira-Moriyama [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Nonmotor symptoms as presenting complaints in Parkinson's disease: A clinicopathological study
000F12 (2007) Jan Zijlmans [Royaume-Uni, Pays-Bas] ; Andrew Evans [Royaume-Uni] ; Flavia Fontes [Royaume-Uni] ; Regina Katzenschlager [Royaume-Uni, Autriche] ; Svetoslav Gacinovic [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Durval Costa [Royaume-Uni, Portugal][123I] FP‐CIT spect study in vascular parkinsonism and Parkinson's disease
000F18 (2007) Andrew Lees (neurologue) [Royaume-Uni]Unresolved issues relating to the Shaking Palsy on the celebration of James Parkinson's 250th birthday
000F61 (2007) Christoph Scherfler [Autriche] ; Johannes Schwarz [Allemagne] ; Angelo Antonini [Italie] ; Donald Grosset [Royaume-Uni] ; Francesc Valldeoriola [Espagne] ; Kenneth Marek [États-Unis] ; Wolfgang Oertel [Allemagne] ; Eduardo Tolosa [Espagne] ; Andrew Lees (neurologue) [Royaume-Uni] ; Werner Poewe [Autriche]Role of DAT‐SPECT in the diagnostic work up of Parkinsonism
000F90 (2007) David A. Gallagher [Royaume-Uni] ; Sean S. O'Sullivan [Royaume-Uni] ; Andrew H. Evans [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Anette Schrag [Royaume-Uni]Pathological gambling in Parkinson's disease: Risk factors and differences from dopamine dysregulation. An analysis of published case series
001072 (2007) Dominic C. Paviour [Royaume-Uni] ; John S. Thornton [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; H. Rolf J Ger [Royaume-Uni]Diffusion‐weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple‐system atrophy from progressive supranuclear palsy
001075 (2007) Bruno Dubois [France] ; David Burn [Royaume-Uni] ; Christopher Goetz [États-Unis] ; Dag Aarsland [Norvège] ; Richard G. Brown [Royaume-Uni] ; Gerald A. Broe [Australie] ; Dennis Dickson [États-Unis] ; Charles Duyckaerts [France] ; Jefferey Cummings [États-Unis] ; Serge Gauthier [Canada] ; Amos Korczyn [Israël] ; Andrew Lees (neurologue) [Royaume-Uni] ; Richard Levy [France] ; Irene Litvan [États-Unis] ; Yoshikuni Mizuno [Japon] ; Ian G. Mckeith [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Eduardo Tolosa [Espagne] ; Murat Emre [Turquie]Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force
001076 (2007) Bernard Ravina [États-Unis] ; Karen Marder [États-Unis] ; Hubert H. Fernandez [États-Unis] ; Joseph H. Friedman [États-Unis] ; William Mcdonald [États-Unis] ; Diane Murphy [États-Unis] ; Dag Aarsland [États-Unis] ; Debra Babcock [États-Unis] ; Jefferey Cummings [États-Unis] ; Jean Endicott [États-Unis] ; Stewart Factor [États-Unis] ; Wendy Galpern [États-Unis] ; Andrew Lees (neurologue) [Royaume-Uni] ; Laura Marsh [États-Unis] ; Mark Stacy [États-Unis] ; Katrina Gwinn-Hardy [États-Unis] ; Valerie Voon [États-Unis] ; Christopher Goetz [États-Unis]Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group
001098 (2007) Murat Emre [Turquie] ; Dag Aarsland [Norvège] ; Richard Brown [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Charles Duyckaerts [France] ; Yoshikino Mizuno [Japon] ; Gerald Anthony Broe [Australie] ; Jeffrey Cummings [États-Unis] ; Dennis W. Dickson [États-Unis] ; Serge Gauthier [Canada] ; Jennifer Goldman [États-Unis] ; Christopher Goetz [États-Unis] ; Amos Korczyn [Israël] ; Andrew Lees (neurologue) [Royaume-Uni] ; Richard Levy [France] ; Irene Litvan [États-Unis] ; Ian Mckeith [Royaume-Uni] ; Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; Christina Sampaio [Portugal] ; Eduardo Tolosa [Espagne] ; Bruno Dubois [France]Clinical diagnostic criteria for dementia associated with Parkinson's disease
001148 (2006) S. Gandhi ; M. M. K. Muqit ; L. Stanyer ; D. G. Healy ; P. M. Abou-Sleiman ; I. Hargreaves ; S. Heales ; M. Ganguly ; L. Parsons ; Andrew Lees (neurologue) [Royaume-Uni] ; D. S. Latchman [Royaume-Uni] ; J. L. Holton ; N. W. Wood ; T. ReveszPINK1 protein in normal human brain and Parkinson's disease
001208 (2006) Dominic C. Paviour [Royaume-Uni] ; Shona L. Price [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Nick C. Fox [Royaume-Uni]Regional brain volumes distinguish PSP, MSA‐P, and PD: MRI‐based clinico‐radiological correlations
001317 (2006) Olivier Rascol [France] ; Bruno Dubois [France] ; Alexandre Castro Caldas [Portugal] ; Stephen Senn [Royaume-Uni] ; Susanna Del Signore [France] ; Andrew Lees (neurologue) [Royaume-Uni]Early piribedil monotherapy of Parkinson's disease: A planned seven‐month report of the REGAIN study
001332 (2006) Andrew H. Evans [Royaume-Uni] ; Nicola Pavese [Royaume-Uni] ; Andrew D. Lawrence [Royaume-Uni] ; Yen F. Tai [Royaume-Uni] ; Silke Appel [Royaume-Uni] ; Miroslava Doder [Royaume-Uni] ; David J. Brooks [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Paola Piccini [Royaume-Uni]Compulsive drug use linked to sensitized ventral striatal dopamine transmission
001370 (2006) Nicolas Pineda-Trujillo [Royaume-Uni, Colombie] ; Maria Apergi [Royaume-Uni] ; Sonia Moreno [Colombie] ; William Arias [Colombie] ; Suzanne Lesage [France] ; Alejandro Franco [Colombie] ; Diego Sepulveda-Falla [Colombie] ; David Cano [Colombie] ; Omar Buriticá [Colombie] ; David Pineda [Colombie] ; Carlos Santiago Uribe [Colombie] ; Justo Garcia De Yebenes [Espagne] ; Andrew Lees (neurologue) [Royaume-Uni] ; Alexis Brice [France] ; Gabriel Bedoya [Colombie] ; Francisco Lopera [Colombie] ; Andres Ruiz-Linares [Royaume-Uni, Colombie]A genetic cluster of early onset Parkinson's disease in a Colombian population
001396 (2005) Katherine Grosset [Royaume-Uni] ; Donald Grosset [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Trial of subtherapeutic pergolide in de novo Parkinson's disease
001461 (2005) Naheed L. Khan ; Shushant Jain ; John M. Lynch ; Nicola Pavese ; Patrick Abou-Sleiman ; Janice L. Holton ; Daniel G. Healy ; William P. Gilks ; Mary G. Sweeney ; Milan Ganguly ; Vaneesha Gibbons ; Sonia Gandhi ; Jenny Vaughan ; Louise H. Eunson ; Regina Katzenschlager ; Juliet Gayton ; Graham Lennox ; Tamas Revesz ; David Nicholl [Royaume-Uni] ; Kailash P. Bhatia ; Niall Quinn ; David Brooks ; Andrew Lees (neurologue) [Royaume-Uni] ; Mary B. Davis ; Paola Piccini ; Andrew B. Singleton [États-Unis] ; Nicholas W. WoodMutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data

List of associated KwdEn.i

Nombre de
documents
Descripteur
22Parkinson's disease
4LRRK2
4apomorphine
4depression
4olfaction
3Lewy bodies
3parkin
3parkinsonism
3smell
2MSA
2PSP
2UPSIT
2autonomic
2diagnosis
2diagnostic criteria
2dopamine agonists
2impulse control disorder
2neuropathology
2progressive supranuclear palsy
2substantia nigra
1ADD = additional integrated image
1AMPA receptor antagonist
1ARSAC = Administration of Radioactive Substances Advisory Committee
1BDI = Beck Depression Inventory
1BP = binding potential
1Brazil
1CingA = anterior cingulate cortex
1DA = dopaminergic; 2DGE = two‐dimensional gel electrophoresis; GFAP = glial fibrillary acidic protein; IR = immunoreactivity, immunoreactive; LB = Lewy body; LN =Lewy neurite; PSP = progressive supranuclear palsy; SN = substantia nigra
1DAT = dopamine transporter
1DJ‐1; Parkinson’s disease; immunohistochemistry; 2D gel electrophoresis; paraquat
1DaTSCAN
1F-dopa PET = 18F-dopa positron emission tomography
1FP‐CIT SPECT
1G2019S mutation
1James Parkinson
1LOD = logarithm of the odds
1LRRK2 = leucine-rich, repeat kinase 2
1LRRK2 mRNA
1LRRK2 protein
1L‐dopa
1L‐dopa challenge
1NAT = noradrenaline transporter
1NFTs = neurofibrillary tangles
1NHNN = National Hospital for Neurology and Neurosurgery
1PARK2
1PARK8
1PD dementia
1PET imaging
1PINK1
1PRKN
1Parkinson
1Parkinson disease
1Parkinson's
1Parkinson's disease dementia
1Parkinson's disease.
1ROI = region of interest
1SNCA
1SPECT
1SPM = statistical parametric mapping
1Sniffin sticks
1Sniffin' Sticks
1Sri Lanka
1Tretiakoff
1UPDRS = Unified Parkinson's Disease Rating Scale
1UPSIT = University of Pennsylvania Smell Identification Test
1adverse effects
1anxiety
1atypical parkinsonism
1cM = centimorgan
1catecholamines
1chronic fatigue syndrome
1clinical diagnostic criteria
1clinical features
1clinical trial
1clinico‐radiological correlations
1compulsions
1conversion disorder
1criteria
1dardarin
1delaying levodopa
1dementia
1differential diagnosis
1diffusion‐weighted MRI
1dopamine disregulation
1dopamine transporter
1dyskinesia
1dyskinesias
1entacapone
1executive functions
1founder effect
1gambling
1genetics
1health status
1impulse control
1impulse control disorders
1juvenile parkinsonism
1levodopa
1levodopa‐induced dyskinesias
1limbic system
1memory

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "Andrew Lees (neurologue)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "Andrew Lees (neurologue)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    Andrew Lees (neurologue)
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024